Correlation Between Spyre Therapeutics and YTLBerhad
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and YTLBerhad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and YTLBerhad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and YTL Berhad, you can compare the effects of market volatilities on Spyre Therapeutics and YTLBerhad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of YTLBerhad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and YTLBerhad.
Diversification Opportunities for Spyre Therapeutics and YTLBerhad
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Spyre and YTLBerhad is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and YTL Berhad in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on YTL Berhad and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with YTLBerhad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of YTL Berhad has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and YTLBerhad go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and YTLBerhad
If you would invest 963.00 in Spyre Therapeutics on September 5, 2024 and sell it today you would earn a total of 1,764 from holding Spyre Therapeutics or generate 183.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. YTL Berhad
Performance |
| Timeline |
| Spyre Therapeutics |
| YTL Berhad |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Spyre Therapeutics and YTLBerhad Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and YTLBerhad
The main advantage of trading using opposite Spyre Therapeutics and YTLBerhad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, YTLBerhad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in YTLBerhad will offset losses from the drop in YTLBerhad's long position.| Spyre Therapeutics vs. Western Union Co | Spyre Therapeutics vs. Freedom Bank of | Spyre Therapeutics vs. Univest Pennsylvania | Spyre Therapeutics vs. NH Foods Ltd |
| YTLBerhad vs. Tradeweb Markets | YTLBerhad vs. Evertz Technologies Limited | YTLBerhad vs. Valneva SE ADR | YTLBerhad vs. Cedar Realty Trust |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |